Cargando…

Medications for analgesia and sedation in the intensive care unit: an overview

Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gommers, Diederik, Bakker, Jan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391270/
https://www.ncbi.nlm.nih.gov/pubmed/18495055
http://dx.doi.org/10.1186/cc6150
_version_ 1782155359215943680
author Gommers, Diederik
Bakker, Jan
author_facet Gommers, Diederik
Bakker, Jan
author_sort Gommers, Diederik
collection PubMed
description Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have proven to reduce the length of intensive care unit stay. To introduce these protocols, new agents or new regimens with the well established agents may be required. In this article we briefly discuss these new regimens and new agents, focusing on the short-acting substances.
format Text
id pubmed-2391270
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23912702008-05-23 Medications for analgesia and sedation in the intensive care unit: an overview Gommers, Diederik Bakker, Jan Crit Care Review Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have proven to reduce the length of intensive care unit stay. To introduce these protocols, new agents or new regimens with the well established agents may be required. In this article we briefly discuss these new regimens and new agents, focusing on the short-acting substances. BioMed Central 2008 2008-05-14 /pmc/articles/PMC2391270/ /pubmed/18495055 http://dx.doi.org/10.1186/cc6150 Text en Copyright © 2008 BioMed Central Ltd
spellingShingle Review
Gommers, Diederik
Bakker, Jan
Medications for analgesia and sedation in the intensive care unit: an overview
title Medications for analgesia and sedation in the intensive care unit: an overview
title_full Medications for analgesia and sedation in the intensive care unit: an overview
title_fullStr Medications for analgesia and sedation in the intensive care unit: an overview
title_full_unstemmed Medications for analgesia and sedation in the intensive care unit: an overview
title_short Medications for analgesia and sedation in the intensive care unit: an overview
title_sort medications for analgesia and sedation in the intensive care unit: an overview
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391270/
https://www.ncbi.nlm.nih.gov/pubmed/18495055
http://dx.doi.org/10.1186/cc6150
work_keys_str_mv AT gommersdiederik medicationsforanalgesiaandsedationintheintensivecareunitanoverview
AT bakkerjan medicationsforanalgesiaandsedationintheintensivecareunitanoverview